Position in MDXG
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$569,759
-$458,204 QoQ
Shares Held
144,243
-5.0% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 20.840526056723725.ToString("F0")%
Shared 0.ToString("F0")%
None 79.15947394327628.ToString("F0")%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. MDXG ranks #149 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in MDXG
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $569,759 | 144,243 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,027,963 | 151,841 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,234,817 | 176,908 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,117,262 | 182,858 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,346,385 | 177,156 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,680,806 | 174,720 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,042,506 | 176,397 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,286,769 | 185,681 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,457,517 | 189,288 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,636,648 | 186,619 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,354,503 | 185,803 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,186,554 | 179,509 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $602,223 | 176,605 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $474,565 | 170,707 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $483,991 | 168,638 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $561,112 | 161,704 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $566,862 | 120,353 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $689,182 | 114,103 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $703,172 | 116,035 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,378,389 | 110,183 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||